Association between DHEAS and Bone Loss in Postmenopausal Women: A 15-Year Longitudinal Population-Based Study
Authors:
Open Access
- 26 July 2011
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 89 (4) , 295-302
Abstract
Our aim was to examine the association between serum dehydroepiandrosterone sulfate (DHEAS) at baseline and BMD change at the femoral neck (FN) and lumbar spine (LS) in postmenopausal women during a 15-year follow-up. All participants were from the Chingford Study. BMD at the FN and LS were measured eight times during the 15-year follow-up by dual-energy X-ray absorptiometry. DHEAS at baseline was measured using radioimmunoassay. Data on height, weight, and hormone-replacement therapy (HRT) status were obtained at each visit. Multilevel linear regression modeling was used to examine the association between longitudinal BMD change at the FN and LS and DHEAS at baseline. Postmenopausal women (n = 1,003) aged 45–68 years (mean 54.7) at baseline were included in the study. After adjustment for baseline age, estradiol, HRT, and BMI, BMD at the FN decreased on average 0.49% (95% CI 0.31–0.71%) per year; and the decline was slowed down by 0.028% per squared year. Increase of DHEAS (each micromole per liter) was associated with 0.49% less bone loss at the FN (95% CI 0.21–0.71%, P = 0.001). However, this strong association became slightly weaker over time. Similar but weaker results were obtained for LS BMD. Our data suggest that high serum DHEAS at baseline is associated with less bone loss at both FN and LS and this association diminishes over time. The nature of the association is unclear, but such an association implies that, in managing BMD loss, women might benefit from maintaining a high level of DHEAS.Keywords
This publication has 35 references indexed in Scilit:
- Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American womenMaturitas, 2007
- Relationship of leptin and sex hormones to bone mineral density in menActa Diabetologica, 2003
- Introduction2002
- Biotransformation of Oral Dehydroepiandrosterone in Elderly Men: Significant Increase in Circulating EstrogensThe Journal of Clinical Endocrinology & Metabolism, 1999
- Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable EstrogenThe Journal of Clinical Endocrinology & Metabolism, 1998
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Bone density at various sites for prediction of hip fracturesThe Lancet, 1993
- Endogenous sex hormones and bone mineral density among community-based postmenopausal womenPostgraduate Medical Journal, 1992
- The relationship between sex steroids and bone mineral content in women soon after the menopauseClinical Endocrinology, 1991
- A relationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating femalesGynecological Endocrinology, 1987